This case study demonstrates how Qinecsa helped implement a robust pharmacovigilance framework designed to support regulatory compliance, operational continuity, and commercialization readiness.

The Challenge

The client faced significant pharmacovigilance challenges following an EMA inspection that resulted in multiple critical findings. To support ongoing development and future commercialization activities, the company required a pharmacovigilance system aligned with the expectations of the FDA, EMA, and other national health authorities.

In addition to addressing regulatory requirements, the organization needed to ensure that its safety operations could support a growing product portfolio, including a product nearing commercialization across multiple regions.

Qinecsa’s Approach

Qinecsa partnered with the client to design and implement a fully compliant pharmacovigilance framework aligned with US, Canadian, and European regulatory requirements. 

Pharmacovigilance System Implementation

The engagement included the design, validation, and implementation of a new safety database to support the client’s pharmacovigilance operations. Qinecsa also managed the migration of a large volume of safety cases into the new environment, helping establish a foundation for compliant and efficient safety management.

Program Management and Governance Support

Recognizing the complexity of the transition, Qinecsa strengthened program management and governance processes to support delivery against demanding timelines. This governance structure helped maintain project oversight while ensuring alignment with regulatory and operational requirements throughout the implementation.

The Solution Delivered

Through a combination of pharmacovigilance consulting, safety database implementation, case migration, and governance support, Qinecsa delivered a comprehensive framework that enabled the client to enhance compliance and prepare for commercialization activities.

The solution was designed to support both immediate regulatory needs and the long-term sustainability of the client’s pharmacovigilance operations. As part of the engagement, Qinecsa also implemented a knowledge retention process to help maintain continuity and support the ongoing delivery of high-quality outputs.

Outcome

The client successfully hosted a subsequent EMA inspection with no critical finding reported as a direct result of Qinecsa’s support. In addition, all project milestones were achieved within the required timeframes despite a challenging transition from the incumbent service provider.

The implemented framework provided a stronger foundation for compliant pharmacovigilance operations while supporting the organization’s commercialization objectives across key global markets.